Document:

Exhibit 10.52

 

LEAK-OUT AGREEMENT

 

August __,
2019

 

This agreement (the
“Leak-Out Agreement”) is being delivered to you in connection with an understanding by and between Inpixon,
a Nevada corporation (the “Company”), and the person or persons named on the signature pages hereto (collectively,
the “Holder”).

 

Reference is hereby
made to (a) the Underwriting Agreement, dated August __, 2019, by and among the Company and Ladenburg Thalmann & Co. Inc.
(“Ladenburg”) and Maxim Group LLC (“Maxim”), as representative of the several underwriters
named therein (the “Underwriting Agreement”), in connection with the underwritten public offering (the “Offering”)
of the Company, pursuant to which the Holder and certain other purchasers acquired (i) shares of voting common stock (“Common
Stock”) of the Company (“Shares”), (ii) Series 6 Convertible Preferred Stock of the Company
(the “Preferred Shares”), (iii) Series A Warrants of the Company to purchase Shares, and (iv) Series B
Warrants of the Company to purchase Shares (the Series A Warrants and Series B Warrants collectively, the “Common
Warrants,” and together with the Shares and Preferred Shares, the “Securities”) and (b) the
registration statement on Form S-1 (File No. 333-232448) (“Registration Statement”).  Capitalized
terms not defined herein shall have the meaning as set forth in the Underwriting Agreement, unless otherwise set forth herein.

  

The Holder agrees solely with the Company
that from the date of the Company’s public announcement of the pricing of the Offering (the “Effective Date”)
and ending at 4:00 pm (New York City time) on the earlier of (i) the date that is seventy-five (75) days after the Effective Date
and (ii) the date on which a total of more than 450,000,000 shares of Common Stock have traded since the Effective Date as reported
by Bloomberg (such period, the “Restricted Period”), neither the Holder, nor any affiliate of such Holder which
(x) had or has knowledge of the transactions contemplated by the Underwriting Agreement, (y) has or shares discretion relating
to such Holder’s investments or trading or information concerning such Holder’s investments, including in respect
of the Securities, or (z) is subject to such Holder’s review or input concerning such affiliate’s investments or trading
(together, the “Holder’s Trading Affiliates”), collectively, shall sell, dispose or otherwise transfer,
directly or indirectly, (including, without limitation, any sales, short sales, swaps or any derivative transactions that would
be equivalent to any sales or short positions) on any Trading Day during the Restricted Period (any such date, a “Date
of Determination”), shares of Common Stock, or shares of Common Stock underlying any Common Stock Equivalents (as defined
in the Underwriting Agreement), held by the Holder on the date hereof, as well as the shares of Common Stock issuable upon conversion
of the Preferred Shares and upon exercise of the Common Warrants (collectively, the “Restricted Securities”),
in an amount representing more than ___%[1] of the trading volume of Common Stock as reported by Bloomberg, LP on each
applicable Date of Determination (“Leak-Out Percentage”); provided, that the foregoing restriction shall not
apply to any actual “long” (as defined in Regulation SHO of the Securities Exchange Act of 1934, as amended) sales
by the Holder or any of the Holder’s Trading Affiliates at a price greater than $___ (in each case, as adjusted for stock
splits, stock dividends, stock combinations, recapitalizations or other similar events occurring after the date hereof); provided,
further, that the foregoing restriction shall not apply to any actual “long” sales of shares of Common Stock purchased
in open market transactions by the Holder or any of the Holder’s Trading Affiliates during the Restricted Period.

 

 

1
Pro rata portion of 35% among investors executing Leak-Out Agreements, based on the aggregate amount to be paid by
each such investor for the Securities. 

  

    1

     

    

 

Notwithstanding anything
herein to the contrary, during the Restricted Period, the Holder may, directly or indirectly, sell or transfer all, or any part,
of any “restricted securities” (as defined in Rule 144) to any Person (an “Assignee”) in a transaction
which does not need to be reported on the consolidated tape on the Company’s principal Trading Market, without complying
with (or otherwise limited by) the restrictions set forth in this Leak-Out Agreement; provided, that as a condition to any such
sale or transfer an authorized signatory of the Company and such Assignee duly execute and deliver a leak-out agreement in the
form of this Leak-Out Agreement (an “Assignee Agreement”, and each such transfer a “Permitted Transfer”)
and, subsequent to a Permitted Transfer, sales of the Holder and the Holder’s Trading Affiliates and all Assignees (other
than any such sales that constitute Permitted Transfers) shall be aggregated for all purposes of this Leak-Out Agreement and Assignee
Agreements.

 

Any notices, consents,
waivers or other communications required or permitted to be given under the terms of this Leak-Out Agreement must be in writing
and shall be given to Ladenburg and Maxim, who subsequently shall deliver such notice, consent, waiver or other communication
to the Company or Holder, as applicable.

 

This Leak-Out Agreement
constitutes the entire agreement among the parties hereto with respect to the subject matter hereof and supersedes all prior negotiations,
letters and understandings relating to the subject matter hereof and are fully binding on the parties hereto.

 

This Leak-Out Agreement
may be executed simultaneously in any number of counterparts. Each counterpart shall be deemed to be an original, and all such
counterparts shall constitute one and the same instrument. This Leak-Out Agreement may be executed and accepted by facsimile or
PDF signature and any such signature shall be of the same force and effect as an original signature.

 

The terms of this
Leak-Out Agreement shall be binding upon and shall inure to the benefit of each of the parties hereto and their respective successors
and assigns.

 

This Leak-Out Agreement
may not be amended or modified except in writing signed by each of the parties hereto.

 

All questions concerning
the construction, validity, enforcement and interpretation of this Leak-Out Agreement shall be governed by Section 16 of the Underwriting
Agreement.

 

Each party hereto
acknowledges that, in view of the uniqueness of the transactions contemplated by this Leak-Out Agreement, the other party or parties
hereto may not have an adequate remedy at law for money damages in the event that this Leak-Out Agreement has not been performed
in accordance with its terms, and therefore agrees that such other party or parties shall be entitled to seek specific enforcement
of the terms hereof in addition to any other remedy it may seek, at law or in equity.

 

    2

     

    

 

The obligations
of the Holder under this Leak-Out Agreement are several and not joint with the obligations of any other holder of any of the
Securities issued under the Underwriting Agreement (each, an “Other Holder”) or any other holder of any of
the Securities issued under the Registration Statement (each, a “Prospectus Purchaser Other Holder”)
pursuant to any other agreement (including, without limitation, any other leak-out agreement (each, an “Other
Leak-Out Agreement”), and the Holder shall not be responsible in any way for the performance of the obligations of
any Other Holder or any Prospectus Purchaser Other Holder under any such other agreement. Nothing contained herein or in this
Leak-Out Agreement, and no action taken by the Holder pursuant hereto, shall be deemed to constitute the Holder and Other
Holders or any Prospectus Purchaser Other Holder as a partnership, an association, a joint venture or any other kind of
entity, or create a presumption that the Holder and the Other Holders or any Prospectus Purchaser Other Holder are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by this Leak-Out Agreement
and the Company acknowledges that the Holder and the Other Holders or any Prospectus Purchaser Other Holder are not acting in
concert or as a group with respect to such obligations or the transactions contemplated by this Leak-Out Agreement or any
other agreement. The Company and the Holder confirm that the Holder has independently participated in the negotiation of the
transactions contemplated hereby with the advice of its own counsel and advisors. The Holder shall be entitled to
independently protect and enforce its rights, including, without limitation, the rights arising out of this Leak-Out
Agreement, and it shall not be necessary for any Other Holder or any Prospectus Purchaser Other Holder to be joined as an
additional party in any proceeding for such purpose.

 

The Company hereby
represents and warrants as of the date hereof and covenants and agrees from and after the date hereof that it will use commercially
reasonable efforts to enforce the provisions of each Other Leak-Out Agreement in accordance with its terms. If the Company becomes
aware that any party to any Other Leak-Out Agreement has breached or failed to comply with any provision of such Other Leak-Out
Agreement, the Company shall use its commercially reasonable efforts to seek specific performance of the terms of such Other Leak-Out
Agreement during the remainder of the Restricted Period.

The Company covenants
that, if the Holder delivers a Notice of Conversion (as defined in the Certificate of Designation) no
later than 12:00 p.m. (New York City time) on the Closing Date to convert any Preferred Shares between the Effective
Date and the Closing Date, the Company shall deliver the Conversion Shares to the Holder on the Closing
Date in connection with such Notice of Conversion.

 

The Company hereby
represents and warrants as of the date hereof and covenants and agrees from and after the date hereof that none of the terms offered
to any Other Holder or any Prospectus Purchaser Other Holder with respect to any restrictions on the sale of Securities substantially
in the form of this Leak-Out Agreement (or any amendment, modification, waiver or release thereof) (each a “Settlement
Document”), is or will be more favorable to such Other Holder than those of the Holder and this Leak-Out Agreement.
If, and whenever on or after the date hereof, the Company enters into a Settlement Document with terms that are materially different
from this Leak-Out Agreement, then (i) the Company shall provide notice thereof to the Holder promptly following the occurrence
thereof and (ii) the terms and conditions of this Leak-Out Agreement shall be, without any further action by the Holder or the
Company, automatically amended and modified in an economically and legally equivalent manner such that the Holder shall receive
the benefit of the more favorable terms and/or conditions (as the case may be) set forth in such Settlement Document, provided
that upon written notice to the Company at any time the Holder may elect not to accept the benefit of any such amended or modified
term or condition, in which event the term or condition contained in this Leak-Out Agreement shall apply to the Holder as it was
in effect immediately prior to such amendment or modification as if such amendment or modification never occurred with respect
to the Holder. The provisions of this paragraph shall apply similarly and equally to each Settlement Document.

 

[The remainder of the page is intentionally
left blank]

 

    3

     

    

 

The parties hereto have executed this Leak-Out Agreement as
of the date first set forth above.

 

	 	Sincerely,	 
	 	 	 
	 	INPIXON	 
	 	 	 	 
	 	By: 	 
	 	 	Name: 	 
	 	 	Title:	 

 

Agreed to and Accepted:

 

	“HOLDER”	 
	 	 	 
	 	 
	 	 	 
	By: 	                                	 
	 	Name: 	 
	 	Title:	 

 

 

4aspn-ex101_228.htm

Exhibit 10.1

 

AMENDMENT TO EXECUTIVE AGREEMENT

This Amendment (“Amendment”), dated as of August 1, 2019, is entered into by and between Aspen Aerogels, Inc., a Delaware corporation (the “Company”), and Donald R. Young (the “Executive”), for purposes of amending that certain Executive Agreement between the parties effective as of January 1, 2019 (the “Executive Agreement”).

RECITALS

Whereas, the Company and the Executive would like to amend the Executive Agreement to extend the length of the “Performance Period” (as defined in the Executive Agreement); and

Whereas, pursuant to Section 10(h) of the Executive Agreement, the Executive Agreement may be amended with the written consent of both parties.

Now, therefore, in consideration of mutual promises and other terms set forth below, the Company and the Executive agree as follows:

	
 
	
1.
	
Amendment.  The Executive Agreement is hereby amended as follows:

The definition of “Performance Period” in Section 1 of the Executive Agreement shall be deleted in its entirety and replaced with the following:

 

“Performance Period” means the approximately three (3) year period commencing on the Effective Date and ending on December 31, 2021.

 

	
 
	
2.
	
Miscellaneous Provisions.  Capitalized terms used but not defined within this Amendment have the meanings specified within the Executive Agreement.  Except as expressly modified by this Amendment, all terms and conditions of the Executive Agreement remain in full force and effect.  This Amendment can be executed by the parties hereto by facsimile and in counterparts, each of which is deemed an original and both of which taken together constitutes one agreement binding upon the parties hereto.  All issues concerning this Amendment shall be governed by and construed in accordance with the laws of the Commonwealth of Massachusetts, without giving effect to any choice of law or conflict of law provision or rule (whether of the Commonwealth of Massachusetts or any other jurisdiction) that would cause the application of the law of any jurisdiction other than the Commonwealth of Massachusetts.

 

In witness whereof, the Parties hereto enter into this Amendment by signing below.

 

 

	
ASPEN AEROGELS, INC.
	
 
	
 
	
 
	
/s/ Donald R. Young

	
 
	
 
	
 
	
 
	
Donald R. Young

	
By:/s/ John Fairbanks
	
 
	
 
	
 
	
 

	
 
	
 
	
 

	
John Fairbanks
	
 
	
 
	
 
	
August 1, 2019

	
Name
	
 
	
 
	
 
	
Date

	
 
	
 
	
 
	
 
	
 

	
Chief Financial Officer
	
 
	
 
	
 
	
 

	
Title
	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 
	
 

	
August 1, 2019 
	
 
	
 
	
 
	
 

	
Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]